证券日报网讯1月8日，四川美丰（000731）在互动平台回答投资者提问时表示，公司严格按照企业会计 准则相关规定对收入进行确认。 ...

证券日报网讯1月6日，文灿股份（603348）在互动平台回答投资者提问时表示，公司严格遵循《企业会 计准则》，对各期末存货进行减值测试并进行相应会计处理，具体会计政策可参见本公司所披露的定期 报告。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 自2020年以来，财政部、国务院国资委、金融监管总局（原银保监会）和证监会连续6年联合发布了"关于严格执行企业会计准则切实做好企业年报工作的 通知"。近三年年报通知中应予以关注的准则实施重点技术问题分布情况如下表所示： | 序号 | 相关问题 | 2025年间题 | 2024年间 | 2023年问 | | --- | --- | --- | --- | --- | | | | 数量 | 题数量 | 题数量 | | 1 | 关于长期股权 | 1 | 1 | 2 | | | 投资 | | | | | 2 | 关于固定资产 | 1 | | 1 | | 3 | 关于无形资产 | 1 | | 1 | | 4 | 关于数据资源 | 1 | 1 | | | 5 | 关于资产减值 | 1 | 2 | 2 | | б | 关于或有事项 | 1 | | | | 7 | 关于收入 | 6 | 3 | 2 | | 8 | 关于政府补助 | 1 | 1 | 3 | | 9 | 关于企业合并 | 2 | | 2 | | 1 0 | 关于租赁 | 1 | | 2 | | 11 | 关于金融 ...

证券日报网讯 12月25日，珠海港在互动平台回答投资者提问时表示，公司根据企业会计准则的要求每 年对商誉进行相应的评估和测试，并严格按照相关规定对外披露，敬请关注公司公告。 （文章来源：证券日报） ...

Macro Highlights - The Ministry of Finance, State-owned Assets Supervision and Administration Commission, Financial Regulatory Administration, and China Securities Regulatory Commission issued a notice emphasizing strict adherence to accounting standards for the preparation of 2025 annual reports, focusing on areas such as long-term equity investments, fixed assets, intangible assets, and revenue recognition [1] Industry News - In November 2025, Chinese brand passenger cars sold 2.169 million units, a month-on-month increase of 1% and a year-on-year increase of 5.8%, accounting for 71.4% of total passenger car sales, with a market share increase of 3.1 percentage points compared to the same period last year [3] - From January to November 2025, sales of Chinese brand passenger cars reached 18.978 million units, a year-on-year increase of 19.4%, representing 69.6% of total passenger car sales, with a market share increase of 4.6 percentage points compared to the same period last year [3] Company News - Kefa Electric announced that three shareholders plan to collectively reduce their holdings by 0.6999% [5] - Tongxingbao's subsidiary signed an operating contract worth 43.166 million yuan [5] - Kangchen Pharmaceutical's KC1086 project received FDA approval to commence clinical trials [5] - Yuantong Biological's methylene blue injection received drug registration approval from the US FDA [6] - Heng Rui Pharmaceutical's SHR-A1904 injection was included in the list of breakthrough therapy products [6] - Yu Huan CNC's wholly-owned subsidiary received a government subsidy of 3.565 million yuan [6] - Kangtai Biological's pentavalent vaccine has entered phase III clinical trials with the first subject enrolled [6] - Duofuduo expects its battery segment capacity to reach 50 GWh by the end of next year, planning to ship around 30 GWh [6]

人民财讯12月24日电，财政部、国务院国资委、金融监管总局、中国证监会发布关于严格执行企业会计 准则 切实做好企业2025年年报工作的通知，企业编制年报应当严格执行财政部发布的企业会计准则、 企业会计准则解释、企业会计准则应用指南、会计处理规定等有关规定，不得编制或提供不符合国家统 一的会计制度要求的会计信息。在此基础上，需要特别关注长期股权投资，固定资产，无形资产，数据 资源，资产减值，或有事项，收入，政府补助，企业合并，租赁，金融工具，标准仓单，保险合同，会 计政策、会计估计变更和差错更正，合并财务报表，关联方及其交易，财务报表编制等领域。 ...

据青岛荣晟企业管理咨询有限公司董事长、资深IPO顾问王立慧对券商中国记者分析，山东高速计提的6.9亿元 减值，并非对东兴证券的投资交易"不划算"，而是在交易预案发布后，将其账面上"虚高"的长期股权投资价 值，向下调整到即将换入的中金公司股票的公允价值水平。这是一个必要的会计技术处理，以确保财务报表反 映交易的经济实质。 12月19日，是东兴证券复牌的第二个交易日。在前一日收获涨停后，19日股价则有所调整，截至收盘，最 终报收14.39元/股，微跌0.35%。 而此前一日，相伴东兴证券9年之久的大股东山东高速公告称，根据相关会计准则及政策，拟在2025年度对联 营企业东兴证券对应的长期股权投资计提减值准备，预计减值准备金额约为6.9亿元。 持股东兴证券已有9年 根据此前公告及财报，山东高速和东兴证券的渊源已久。2016年，东兴证券通过定增再融资。山东高速获配 1.20亿股，跻身东兴证券第二大股东，持股比例为4.35%。彼时，定增的每股发行价格为18.81元，以此计算， 山东高速共耗资22.57亿元。 2021年，山东高速减持了东兴证券部分股权，并于2022年又增持至原有股份数量。此后至今，山东高速直接持 有东兴 ...

证券日报网讯12月4日，武商集团（000501）在互动平台回答投资者提问时表示，公司自持的物业资产 主要用于自主经营，公司根据《企业会计准则》规定，采用成本法核算能真实、准确地反映公司的资产 价值。 ...

致同连续多年持续跟踪研究上市公司年报执行企业会计准则情况，正陆续发布"上市公司年报分析之准则应用披露示例"系列文章。主要研究内容是结合上 市公司年报披露示例，解析上市公司重点企业会计准则和监管要求的执行情况和可以借鉴的实务应用案例，包括执行准则和监管要求的重大会计政策的选 用、重要会计估计的判断、重点关注问题的实务应用示例、核心会计事项的披露示例等。 第三十四条 企业应当根据其在向客户转让商品前是否拥有对该商品的控制权，来判断其从事交易时的身份是主要责任人还是代理人。企业在向客户转让 商品前能够控制该商品的，该企业为主要责任人，应当按照已收或应收对价总额确认收入；否则，该企业为代理人，应当按照预期有权收取的佣金或手续 费的金额确认收入，该金额应当按照已收或应收对价总额扣除应支付给其他相关方的价款后的净额，或者按照既定的佣金金额或比例等确定。 系列文章研究涉及的准则和监管要求包括：长期股权投资准则（CAS2）、企业合并准则（CAS20）、合并报表准则（CAS33）、政府补助准则 （CAS16）、股份支付准则（CAS11）、资产减值准则（CAS8）、会计政策、会计估计变更和差错更正准则（CAS28）、或有事项准则 ...

Core Viewpoint - Changyu Group is undergoing a second round of IPO review by the Shanghai Stock Exchange, addressing key issues related to consolidated financial statements, industry representation, and accounting treatment [1][2]. Group 1: IPO Details - Changyu Group's IPO was accepted on May 21, 2025, with a fundraising target of 7.13 billion yuan [2]. - The company is primarily engaged in the research, production, and sales of zirconium products, specialty nylon products, and fine chemical products [2]. - The IPO proceeds will be used for projects including 45,000 tons of ultra-pure zirconium chloride and 10,000 tons of high-performance nylon elastomer products [3]. Group 2: Financial and Operational Performance - The company reported fluctuating financial performance from 2022 to mid-2025, with revenues of 1.669 billion yuan, 1.608 billion yuan, 1.638 billion yuan, and 897 million yuan, and net profits of 263 million yuan, 195 million yuan, 212 million yuan, and 113 million yuan respectively [9]. - The average selling price of zirconium products has been declining, with prices of 24,000 yuan/ton, 20,200 yuan/ton, 18,000 yuan/ton, and 17,800 yuan/ton over the reporting periods [10][11]. - The gross profit margin for the main business has shown volatility, with rates of 28.35%, 23.27%, 23.83%, and 23.54% during the reporting periods [10]. Group 3: Market Position and Industry Representation - Changyu Group claims to be the largest producer of zirconium chloride globally, with a production capacity of 75,000 tons per year [5]. - The company estimates a domestic market share of approximately 29.64% and a global market share of about 22.62% for zirconium chloride in 2024 [6]. - The Shanghai Stock Exchange has requested further evidence regarding the company's market share and industry ranking [5]. Group 4: Accounting and Compliance Issues - The Shanghai Stock Exchange raised concerns about the consolidation of joint ventures, questioning whether Changyu Group has control over its joint ventures based on their governance structures [4]. - The company has defended its accounting treatment of CIF shipping costs, asserting compliance with international trade terms and accounting standards [8].